Linde PLC (NYSE:LIN) has been assigned a consensus rating of “Buy” from the nineteen research firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and twelve have issued a buy rating on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $200.35.
A number of brokerages have commented on LIN. UBS Group reiterated a “buy” rating on shares of Linde in a research report on Friday, July 12th. ValuEngine upgraded Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Monday, April 1st. Zacks Investment Research lowered HEXO from a “hold” rating to a “sell” rating in a research report on Wednesday, May 15th. SunTrust Banks decreased their price objective on Perrigo to $46.00 and set a “hold” rating on the stock in a research report on Thursday, April 4th. Finally, DZ Bank upgraded Linde to a “buy” rating in a research report on Friday, May 17th.
NYSE LIN traded down $0.26 during trading hours on Friday, reaching $203.38. 1,228,262 shares of the company’s stock were exchanged, compared to its average volume of 1,529,546. The company has a market cap of $110.82 billion, a PE ratio of 31.83, a PEG ratio of 2.19 and a beta of 0.77. Linde has a one year low of $145.95 and a one year high of $205.55. The business’s fifty day simple moving average is $199.91. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.35.
In other news, VP Eduardo F. Menezes sold 19,056 shares of the stock in a transaction on Friday, May 17th. The stock was sold at an average price of $188.23, for a total value of $3,586,910.88. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Stephen F. Angel sold 56,574 shares of the stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $197.27, for a total value of $11,160,352.98. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by company insiders.
Several hedge funds have recently bought and sold shares of LIN. Comerica Securities Inc. acquired a new position in shares of Linde in the 4th quarter valued at $309,000. First Trust Advisors LP acquired a new position in shares of Linde in the 4th quarter valued at $416,000. GSA Capital Partners LLP acquired a new position in shares of Linde in the 4th quarter valued at $318,000. Great West Life Assurance Co. Can acquired a new position in shares of Linde in the 4th quarter valued at $860,000. Finally, Bessemer Group Inc. acquired a new position in shares of Linde in the 4th quarter valued at $120,000. 72.83% of the stock is currently owned by institutional investors.
Linde Company Profile
Linde plc operates as an industrial gas company in primarily North and South America, Europe, the Middle East, Africa, the Asia Pacific, and South Korea. The company offers oxygen, nitrogen, argon, rare gases, carbon monoxide, carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.
Featured Story: Dow Jones Industrial Average (DJIA)
Receive News & Ratings for Linde Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde and related companies with MarketBeat.com's FREE daily email newsletter.